ANN ARBOR, Mich., Jan. 25, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has signed an agreement with Miller Veterinary Supply ("Miller") for...
Zomedica CEO Issues Shareholder Letter as TRUFORMA™ Nears Commercialization
ANN ARBOR, Mich., Jan. 18, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today issued the following letter from Robert Cohen, Chief Executive...
Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA™
ANN ARBOR, Mich., Jan. 04, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced the appointment of Robert Cohen as Chief Executive Officer...
Zomedica to Remain Domiciled in Canada
Progress Continuing Toward Commercialization of TRUFORMA™ANN ARBOR, Mich., Dec. 15, 2020 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today...
Zomedica Completes Internal “Launch Team” for Upcoming TRUFORMA™ Commercialization
ANN ARBOR, Mich., Dec. 07, 2020 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, with the hiring of Debra Rock to lead the Company's...
Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™
Certain assays under development are believed to be the first ever for use at the point-of-care and the first ever available in veterinary medicineANN ARBOR, Mich., Nov. 13, 2020 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health...